Lfng - LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase Gene

Rattus norvegicus

Gene ID: 170905 | Gene type: protein coding

About Lfng

Summary

Predicted to enable O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity. Predicted to be involved in lymphocyte differentiation; negative regulation of Notch signaling pathway involved in somitogenesis; and somitogenesis. Predicted to act upstream of or within several processes, including compartment pattern specification; positive regulation of Notch signaling pathway; and regulation of somitogenesis. Predicted to be integral component of Golgi membrane. Human ortholog(s) of this gene implicated in spondylocostal dysostosis. Orthologous to human LFNG (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase). [provided by Alliance of Genome Resources, Apr 2022]

Lfng Products(1)

mRNA	Protein	Name
NM_133393.2	NP_596884.1	beta-1,3-N-acetylglucosaminyltransferase lunatic fringe precursor

Protein Preferred Names

Protein Names

beta-1,3-N-acetylglucosaminyltransferase lunatic fringe

O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase

lunatic fringe gene homolog

Related Agents

Pre-clinical Phase

Bioactive Molecules (3)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-RS07601	LFNG Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS22217	Lfng Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS28739	Lfng Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	Lfng	NCBI	NCBI:3955

Name
Email *

	Sorry, but the email address you supplied was invalid.